Xenograft Services PPT

Download Report

Transcript Xenograft Services PPT

Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery & Therapeutics

Services >

Xenograft

Benefits of Xenograft

 Develop new therapeutic agents quickly, efficiently and cost effectively  Evaluate the efficacy and toxicity of potential therapeutic agents www.signalsblog.ca

Xenotransplantation is the transplantation of living cells, tissues or organs from one species to another.

  Evaluate target compound activity using

in vivo

system (human cells) Predict cytotoxicity of cancer drugs

Altogen Labs • 4020 S Industrial Dr • Suite 130 • Austin • TX • 78744 • USA [email protected] • 512.433.6177

www.wikipedia.org

Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery & Therapeutics

Services >

Xenograft

The Gold Standard in Oncology

In vivo

xenograft efficacy evaluations remain the gold standard and the workhorse of oncology preclinical research.

 Xenograft models combine the advantages of working with human cancers with the physiological relevance of an

in vivo

host.

 Typically, immunodeficient mice serve as hosts for a wide variety of human tumors, effectively serving as proxies for human subjects.

 Xenograft models remain a mainstay in oncology research, playing a key role in drug discovery and development.

Altogen Labs • 4020 S Industrial Dr • Suite 130 • Austin • TX • 78744 • USA [email protected]

• 512.433.6177

Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery & Therapeutics

Services >

Xenograft

Assay Pipelines

Pipeline Xenograft Assay I

We design your experiment based on your project requirements. Through years of experience and literature search we guarantee optimal experimental setup according to selection of mice stain, cell lines, inoculation and dosage.

Pipeline Assay II - test a compound

You send us a compound and cell line to establish xenograft. We establish xenograft animal models and test compound activity and how it affects tumor growth in an established xenograft model. 

Pipeline Xenograft Assay III - test a cell line

You send us a cell line and we test it’s ability to establish tumor growth in standard immunodeficient mice.

Altogen Labs • 4020 S Industrial Dr • Suite 130 • Austin • TX • 78744 • USA [email protected]

• 512.433.6177

Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery & Therapeutics

Services >

Xenograft

Experimental Objectives of Compound Testing

       How does the test compound affect tumor growth? Does the test compound inhibit tumor invasion or metastasis? Localization of test compound in the tumor?

Define drug characteristics:

 Bioavailability   Toxicity Efficacy  Potency Is cell line tumorigenic? Changes in gene expression upon treatment or gene manipulation

ParamHow does gene manipulation in a cell line affect following parameters:

 Tumor growth , Invasiveness, Metastasis

Altogen Labs • 4020 S Industrial Dr • Suite 130 • Austin • TX • 78744 • USA [email protected]

• 512.433.6177

www.skyepharma.com

Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery & Therapeutics

Services >

Xenograft

Basic Study Design

Xenograft studies can be designed to identify lead compounds, optimize dose schedules, and identify combination strategies.

Altogen Labs • 4020 S Industrial Dr • Suite 130 • Austin • TX • 78744 • USA [email protected]

• 512.433.6177

Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery & Therapeutics

Services >

Xenograft

Service Options

      Use in-house or customer-provided cell lines or tumor Begin testing a compound immediately after injecting mice with tumor cells (unstaged) or once the tumors reach a certain size (staged) Assign mice to groups randomly or stratify them by body weight, tumor size, disease factors, or any combination of parameters Administer test compounds by any of the following methods: topically, IP, IV, SC, PO, high pressure tail vein, osmotic minipumps (SC or IP), SC drug pellets, or in the food or water Snap freeze harvested tumors or fix them for histology or other specialized assays Analyze blood chemistry at various times throughout the study

Altogen Labs • 4020 S Industrial Dr • Suite 130 • Austin • TX • 78744 • USA [email protected]

• 512.433.6177

Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery & Therapeutics

Services >

Xenograft

Sample of Cell Lines Maintained at Altogen Labs

Cell Line Organ Disease

A549 Lung Carcinoma DU145 Prostate Carcinoma PC3 LNCaP Prostate Prostate Adenocarcinoma Carcinoma MDA-MB-231 FaDu Caki -1 Caki - 2 PANC-1 SK-MEL-2 SK-OV-3 U-87 MG A431 SW-480 HeLa Breast Pharynx Kidney Kidney Pancreas Skin Ovary Brain Epidermis Colon Cervix Adenocarcinoma Squamous carcinoma Clear Cell Carcinoma Clear Cell Carcinoma Epithiloid Carcinoma Malignant Melanoma Adenocarcinoma Glioblastoma/ Astrocytoma Epidermoid Carcinoma Adenocarcinoma Adenocarcinoma

Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery & Therapeutics

Services >

Xenograft

Growth rates for different cell lines

Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery & Therapeutics

Services >

Xenograft

Administration Options

  

Route of dose:

 Intratumoral   Intramuscular Oral   Intravenous Intratracheal  Subcutaneous  Intraperitoneal

Frequency of dose Duration of dose

www.patient-derived-xenograft-services.com

Altogen Labs • 4020 S Industrial Dr • Suite 130 • Austin • TX • 78744 • USA [email protected]

• 512.433.6177

Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery & Therapeutics

Services >

Xenograft

Endpoints

 Estimated tumor volume (L x W 2 /2)  Mean/median time to specified tumor volume  Survival time to specified tumor volume  Tumor doubling time  Tumor growth inhibition (TGI)  Tumor growth delay (TGD)  Increased life span (ILS)  Tumor cell kill rate

Altogen Labs • 4020 S Industrial Dr • Suite 130 • Austin • TX • 78744 • USA [email protected]

• 512.433.6177

Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery & Therapeutics

Services >

Xenograft

        

Additional Analysis Options

Clinical observations every day Haematology analysis (blood cell count) Clinical chemistry profile (of urine and plasma) Evaluate the degree of metastasis. Characterization of the tumor (necrosis, etc) The tumor is divided and preserved for further analysis Cryo-preservation (for cell culture) Formalin fixed tumors and tissues (for histopathological and immunostaining analysis) RNAlater fixed tumors and tissues (for RNA and DNA isolation, and gene expression analysis)

Altogen Labs • 4020 S Industrial Dr • Suite 130 • Austin • TX • 78744 • USA [email protected]

• 512.433.6177